ARTICLE | Clinical News
APC 2059: Update
March 12, 2001 8:00 AM UTC
Axys Pharmaceuticals Inc. (AXPH), South San Francisco, Calif. Product: APC 2059 Business: Autoimmune/Inflammation Therapeutic category: Immune suppression Target: Tryptase enzyme Description: Subcuta...